CUMBERLAND PHARMACEUTICALS I COM

CUMBERLAND PHARMACEUTICALS I COM is a security (CUSIP 230770109) tracked across SEC portfolio filings. 31 institutional managers reported $10.0M on Form 13F as of 2026-06-30; 2 registered fund positions totaling $483K via N-PORT as of 2026-04-30.

Summary

Top institutional holders (Form 13F)

Showing 15 of 31 managers by value.

ManagerLocationValueShares
Ikarian Capital, LLCDALLAS, TX$1.8M553,153
VANGUARD GROUP INCValley Forge, PA$1.6M411,786
RENAISSANCE TECHNOLOGIES LLCNEW YORK, NY$1.5M470,696
DIMENSIONAL FUND ADVISORS LPAUSTIN, TX$898K276,359
PERCEPTIVE ADVISORS LLCNEW YORK, NY$640K196,978
BRIDGEWAY CAPITAL MANAGEMENT, LLCHOUSTON, TX$531K163,468
BOOTHBAY FUND MANAGEMENT, LLCNEW YORK, NY$415K127,694
Bank of New York Mellon CorpNEW YORK, NY$379K58,458
GEODE CAPITAL MANAGEMENT, LLCBOSTON, MA$371K114,293
J. Goldman & Co LPNEW YORK, NY$263K81,040
SUSQUEHANNA INTERNATIONAL GROUP, LLPBALA CYNWYD, PA$239K
JANE STREET GROUP, LLCNEW YORK, NY$191K14,607
BlackRock, Inc.New York, NY$185K56,891
CITADEL ADVISORS LLCMIAMI, FL$162K16,643
BAILARD, INC.Foster City, CA$160K24,624

Top fund holders (N-PORT)

FundRegistrantValue% of fund
VANGUARD EXTENDED MARKET INDEX FUNDVANGUARD INDEX FUNDS$283K0.03%
U.S. MICRO CAP PORTFOLIODFA INVESTMENT DIMENSIONS GROUP INC$200K0.27%

More